Jun 19 2010
WaferGen Biosystems, Inc. (OTC:WGBS) (BULLETIN BOARD: WGBS) , a leading developer of state-of-the-art genetic analysis systems, today announced that scientists from Kyoto University will use the WaferGen SmartChip Real-Time PCR System to identify and compare biomarkers to advance their research to regenerate tissues such as bone, cartilage, and muscle, lost or reduced due to various causes.
Kyoto University is one of ten early-access customers using the SmartChip platform to advance research results through the improved discovery and validation of biomarkers enabled by its high-throughput capability.
The researchers at Kyoto University are led by Professor Shinya Yamanaka, M.D., Ph.D., Director of Kyoto University's Center for iPS Cell Research and Application (CiRA), and a recent recipient of both the Imperial Prize as well as the Japan Academy Prize. They are using the SmartChip platform to better identify and compare biomarkers, important to the clarification of iPS cells.
"We are pleased that a university of the stature of Kyoto -- in existence for more than 100 years with more than 22,000 students today -- has chosen our SmartChip System as part of their ground-breaking research project," said Alnoor Shivji, chairman and CEO, WaferGen. "By providing both the discovery and validation of biomarkers on one platform, SmartChip enables more extensive gene analysis, a key component in the advancement of important new therapies such as regenerative treatments."
Source: http://www.wafergen.com/